Literature DB >> 9617875

The protective effect of a persistent trigeminal artery on brain stem infarctions: a follow-up case report.

Y Ito1, H Watanabe, H Niwa, S Hakusui, T Ando, T Yasuda, G Sobue, T Yanagi.   

Abstract

A persistent trigeminal artery (PTA) represents an embryonic vascular anastomosis connecting the carotid and basilar arterial systems. Little is known about its protective role in cases of basilar artery occlusion. We followed up a 63-year-old man who had suffered a brain stem infarction due to basilar artery stenosis and was found to have a PTA. Although a second brain stem infarction due to basilar artery occlusion developed, the circulation to the brain stem was well maintained via collateral flow from the PTA, and the patient demonstrated good recovery. A PTA may function as an anastomosis between the carotid and basilar systems, thus preventing a more serious infarction.

Entities:  

Mesh:

Year:  1998        PMID: 9617875     DOI: 10.2169/internalmedicine.37.334

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Basilar stroke from a persistent hypoglossal artery.

Authors:  Alfred P See; Jacob F Baranoski; Bruno C Flores; Andrew Ducruet; Felipe C Albuquerque
Journal:  BMJ Case Rep       Date:  2017-01-27

Review 2.  Clinical Importance of the Persistent Primitive Trigeminal Artery in Vascular Lesions and Its Role in Endovascular Treatment.

Authors:  Yiheng Wang; Jinlu Yu
Journal:  Front Neurol       Date:  2022-07-11       Impact factor: 4.086

3.  Acute Ischemic Stroke Involving Both Anterior and Posterior Circulation Treated by Endovascular Revascularization for Acute Basilar Artery Occlusion via Persistent Primitive Trigeminal Artery.

Authors:  Taichiro Imahori; Atsushi Fujita; Kohkichi Hosoda; Eiji Kohmura
Journal:  J Korean Neurosurg Soc       Date:  2016-07-08

4.  Persistent trigeminal artery in a patient with posterior circulation stroke treated with rt-PA: case report.

Authors:  Axel Ferreira; Paulo S Coelho; Vítor Tedim Cruz
Journal:  BMC Neurol       Date:  2019-10-27       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.